Effect of antioxidant trace elements on the response of cardiac tissue to oxidative stress

Annals of the New York Academy of Sciences

Volumn 874, Issue , 1999, Pages 138-155

  Barandier, Christine ^a   Tanguy, Stéphane ^a   Pucheu, Sylvie ^a   Boucher, Francois ^a   De Leiris, Joël ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COPPER; MANGANESE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SELENIUM; TRACE ELEMENT; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DIETARY INTAKE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY;

EID: 0032800177     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09232.x     Document Type: Conference Paper

References (84)

1. 1. PERRY, H.M. et al. 1991. Concentration of trace metals (Cd, Zn, Se, Cu, Cr and Fe) in organs (heart, kidney and liver) of subjects with myocardial infarction or hypertension. WHO/IAEA Myocardial Infarction and Hypertension Autopsy Study. J. Trace Elem. Exp. Med. 4: 109-128.
2. 2. PUCHEU, S. et al. 1995. Time-course of changes in plasma levels of trace elements after thrombolysis during the acute phase of myocardial infarction in humans. Biol. Trace Elem. Res. 47: 171-182.
3. 3. KUSLEIKAITE, M. & R. MASIRONI. 1996. Trace elements in prognosis of myocardial infarction and sudden coronary death. J. Trace Elem. Exp. Med. 9: 57-62.
4. 4. BOLLI, R. 1991. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc. Drugs Ther. 5: 249-268.
5. 5. HEARSE, D.J. 1992. Stunning: a radical review. In Stunning, Hibernation, and Calcium in Myocardial Ischemia and Reperfusion. L.H. Opie, Eds: 10-55. Kluwer Academic Publishers. Boston, MA.
6. 6. GUARNIERI, C. et al. 1996. Alpha-tocopherol pretreatment improves endothelium-dependent vasodilation in aortic strips of young and aging rats exposed to oxidative stress. Mol. Cell. Biochem. 157: 223-228.
7. 7. GARLICK, P.B. et al. 1987. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ. Res. 61: 757-760.
8. 8. BOLLI, R. et al. 1989. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial stunning is a manifestation of reperfusion injury. Circ. Res. 65: 607-622.
9. 9. ARROYO, C.M. et al. 1987. Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Lett. 221: 101-104.
10. 10. BAKER, J.E. et al. 1988. Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc. Natl. Acad. Sci. USA 85: 2786-2789.
11. 11. CHARLON, V. & J. DE LEIRIS. 1988. Ability of N-tert-butyl alpha phenylnitrone (PBN) to be used in isolated perfused rat heart spin trapping experiments: preliminary studies. Basic Res. Cardiol. 83: 306-313.
12. 12. BOUCHER, F. et al. 1992. Evidence of cytosolic iron release during post-ischaemic reperfusion of isolated rat hearts. Influence of spin-trapping experiments with DMPO. FEBS Lett. 302: 261-264.
13. 13. Yu, B.P. 1994. Cellular defenses against damage from reactive oxygen species, Physiol. Rev. 74: 139-162.
14. 14. JI, L.L. et al. 1992. Antioxidant enzyme response to selenium deficiencies in rat myocardium. J. Am. Coll. Nutr. 11: 79-86.
15. 15. FRIDOVICH, I. 1995. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64: 97-112.
16. 16. FLORES, S.C. et al. 1993. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 90: 7632-7636.
17. 17. SINGH, R.K. et al. 1992. Potential use of simple manganese salts as antioxidant drugs in horses. Am. J. Vet. Res. 53: 1822-1829.
18. 18. COASSIN, M. et al. 1992. Antioxidant effect of manganese. Arch. Biochem. Biophys. 299: 330-333.
19. 19. CHIPPERFIELD, B. 1978. Dietary factors in the development of ischaemic heart disease. Chest 3: 3-9.
20. 20. MERTZ, W. 1982. Trace minerals and atherosclerosis. Fed. Proc. 41: 2807-2812.
21. 21. CHIPPERFIELD, B. 1986. Metals and ischemic heart disease. Rev. Environ. Health 6: 209-250.
22. 22. BRAY, T.M. & W.J. BETTGER. 1990. The physiological role of zinc as an antioxidant. Free Radical Biol. Med. 8: 281-291.
23. 23. COUDRAY, C. et al. 1992. Superoxide dismutase activity and zinc status: a study in animals and man. J. Nutr. Med. 3: 13-26.
24. 24. SEARLE, A.J.F. & A. TOMASI. 1982. Hydroxyl free radical production in iron-cystein solutions and protection by zinc. J. Inorg. Biochem. 17: 161-166.
25. 25. COUDRAY, C. et al. 1993. Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts. Int. J. Cardiol. 41: 109-113.
26. 26. JAIN, V.K. & G. MOHAN. 1991. Serum zinc and copper in myocardial infarction with particular reference to prognosis. Biol. Trace Elem. Res. 31: 317-322.
27. 27. FAURE, P. et al. 1991. Effect of an acute zinc depiction on rat lipoproteine and peroxidation. Biol. Trace Elem. Res. 28: 135-146.
28. 28. BURK, R.F. 1989. Recent developments in trace element metabolism and function: newer roles of selenium in nutrition. J. Nutr. 119: 1051-1054.
29. 29. WHANGER, P.D. 1989. China, a country with both selenium deficiency and toxicity: some thoughts and impressions. J. Nutr. 119: 1236-1239.
30. 30. ROTRUCK, J.T. et al. 1973. Selenium: biochemical role as component of glutathione peroxidase. Science 179: 588-590.
31. 31. NOUGUCHI, T. et al. 1973. Mode of action of selenium and Vit. E in prevention of exudative diathesis in chicks. J. Nutr. 103: 1502-1511.
32. 32. MERCURIO, F.D. 1986. Selenium-dependent glutathione peroxidase inhibitors increase toxicity of pro-oxidant compounds. J. Nutr. 116: 1726-1734.
33. 33. KOK, F. et al. 1989. Decreased selenium levels in acute myocardial infarction. J. Am. Med. Assoc. 261: 1161-1164.
34. 34. BEAGLEHOLE, R. et al. 1990. Decreased blood selenium and risk of myocardial infarction. Int. J. Epidemiol. 19: 918-922.
35. 35. SUADICANI, P. et al. 1992. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 96: 33-42.
36. 36. KONZ, K.H. et al. 1991. Selenium as a protector of diastolic function during oxidant stress. J. Trace Elem. Elect. H. 5: 87-93.
37. 37. POLTRONIERI, R. et al. 1992. Protective effect of selenium in cardiac ischemia and reperfusion. Cardioscience 3: 155-160.
38. 38. HASSAN, H.M. 1988. Biosynthesis and regulation of superoxide dismutases. Free Radical Biol. Med. 5: 377-385.
39. 39. ALLEN, C.B. & J.T. SAARI. 1993. Isolated hearts from copper-deficient rats exhibit improved postischemic contractile performance. J. Nutr. 123: 1794-1800.
40. 40. FIELDS, M. et al. 1991. The severity of copper deficiency can be ameliorated by deferoxamine. Metabolism 40: 105-109.
41. 41. CHAO, P.Y. & K.G. ALLEN. 1992. Glutathione production in copper-deficient isolated rat hepatocytes. Free Radical Biol. Med. 12: 145-150.
42. 42. KLEVAY, L.M. & E.K. VIESTENZ. 1981. Abnormal electrocardiograms in rats deficient in copper. Am. J. Physiol. 240: H185-189.
43. 43. KOPP, S.J. et al. 1983. Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency. Am. J. Physiol. 245: H855-856.
44. 44. ARCHIBALD, F.S. & I. FRIDOVICH. 1982. The scavenging of superoxide radical by manganese complexes: in vitro. Arch. Biochem. Biophys. 214: 452-463.
45. 45. BORELLO, S. et al. 1992. Transcriptional regulation of MnSOD by manganese in the liver of manganese deficient mice and during rat development. Biochemistry Int. 28: 595-601.
46. 46. PAYNTER, D.I. 1980. Changes in activity of the manganese superoxide dismutase enzyme in tissue of the rat with changes in dietary manganese. J. Nutr. 110: 437-447.
47. 47. DAVIS, C.D. & J.L. GREGER. 1992. Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am. J. Clin. Nutr. 55: 747-752.
48. 48. HUSSAIN, S. et al. 1997. The effects of chronic exposure of manganese on antioxidant enzymes in different regions of rat brain. Neurosci. Res. Commun. 21: 135-144.
49. 49. PUCHEU, S. 1994. Contribution à l'étude des manifestations physiopathologiques liées au stress oxydatif intervenant lors de la reperfusion du myocarde ischémique: rôle des oligoéléments et essais de protection par des molécules antioxydantes. Ph.D. thesis, Joseph Fourier University, Grenoble, France.
50. 50. PRZYLENK, K. & R.A. KLONER. 1986. Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium." Circ. Res. 58: 148-156.
51. 51. BOLLI, R. 1991. Superoxide dismutase 10 years later: A drug in search of use. J. Am. Coll. Cardiol. 18: 231-233.
52. 52. STADTMAN, E.R. et al. 1990. Manganese-dependent disproportionation of hydrogen peroxide in bicarbonate buffer. Proc. Natl. Acad. Sci. USA 87: 384-388.
53. 53. VARANI, J. et al. 1991. Hydrogen peroxide-induced cell and tissue injury: protective effect of Mn. Inflammation 15: 291-301.
54. 54. BRUROK, H. et al. 1995. Effects of manganese dipyridoxyl diphosphate, dipyridloxyl diphosphate, and manganese chloride on cardiac function. Invest. Radiol. 30: 159-167.
55. 55. BRUROK, H. et al. 1997. Manganese and the heart: acute cardiodepression and myocardial accumulation of manganese. Acta Physiol. Scand. 159: 33-40.
56. 56. BARANDIER, C.E. et al. 1998. Manganese reduces myocardial reperfusion injury on isolated rat heart. J. Mol. Cell. Cardiol. 30: 837-847.
57. 57. LINDBERG, O. & L. EKNSTER. 1954. Manganese, as a co-factor of oxidative phosphorylation. Nature 173: 1038-1039.
58. 2+-induced inhibition of ATP synthesis in brain mitochondria. FEBS Lett. 154: 247-250.
59. 59. KENSLER, T.W. et al. 1983. Inhibition of tumor promotion by a biomimetic SOD. Science 221: 75-77.
60. 60. YAMAMOTO, S. et al. 1990. Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt. Carcinogenesis 11: 749-754.
61. 61. HERNANDEZ, L.A. et al. 1987. Effects of Cu-DTPS on ischemia-reperfusion injury. In Biology of Copper Complexes. J.R.J. Sorenson, Ed.: 201-214. Humana Press. Clifton, NJ
62. 62. SORENSON, J.R.J. 1989. Copper complexes offer a physiological approach to treatment of chronic diseases. Prog. Med. Chem. 26: 437-568.
63. 63. NAGELE, A. et al. 1993. Induction of oxidative stress and protection against hydrogen peroxide-mediated cytotoxicity by the superoxide dismutase-mimetic complex copper-putrescine-pyridine. Biochem. Pharmacol. 47: 555-562.
64. 2+-chelates studied by pulse radiolysis. FEBS Lett. 47: 72-75.
65. 65. ARENA, G. et al. 1993. Cytotoxic and cytostatic activity of copper(II) complexes. Importance of the speciation for the correct interpretation of the in vitro biological results. J. Inorg. Biochem. 50: 31-45.
66. 2. Arch. Biochem. Biophys. 271: 149-156.
67. 67. DARR, D. et al. 1987. A mimic of superoxide dismutase activity based upon desferrioxamine B and manganese (IV). Arch. Biochem. Biophys. 258: 351-355.
68. 68. RILEY, D.P. & R.H. WEISS. 1994. Manganese macrocyclic ligand complexes as mimics of superoxide dismutase. J. Am. Chem. Soc. 116: 387-388.
69. 69. WEISS, R.H. et al. 1993. Evaluation of activity of putative superoxide dismutase mimics: direct analysis by stopped-flow kinetics. J. Biol. Chem. 268: 23049-23054.
70. 70. KlLGORE, K.S. et at. 1994. Protective effects of the SOD-mimetic SC-52608 against ischemia-reperfusion damage in the rabbit isolated heart. J. Mol. Cell. Cardiol. 26: 995-1006.
71. 71. FAULKNER, K.M. et al. 1994. Stable Mn (II) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem. 269: 23471-23476.
72. 72. HARDY, M.M. et al. 1994. Superoxide dismutase mimetics inhibit neutrophil-mediated human aortic endothelial cell injury in vitro. J. Biol. Chem. 269: 18535-18540.
73. 73. BAUDRY, M. et al. 1993. Salen-manganese complexes are superoxide dismutase-mimics. Biochem. Biophys. Res. Commun. 192: 964-968.
74. 74. MALFROY-CAMINE, B. & M. BAUDRY. 1995. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease. U.S. Patent #5,403,834. April, 4.
75. 75. GONZALEZ, P.K. et al. 1995. EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J. Pharmacol. Exp. Ther. 275: 798-806.
76. 76. MCCORD, J.M. et al. 1973. Superoxide and superoxide dismutase. In Oxidases and Related Redox Systems. University Press. Baltimore, MD
77. 77. PUCHEU, S. et al. 1995. Protective effect of superoxide scavenger EUK8 against ultrastructural alterations induced by ischemia and reperfusion in isolated rat hearts. Nutrition 11: 582-584.
78. 78. PUCHEU, S. et al. 1996. A synthetic catalytic scavenger of reactive oxygen species protects isolated iron-overloaded rat heart from functional and structural damage induced by ischemia/reperfusion. Cardiovasc, Drugs Ther. 10: 331-339.
79. 79. MUSLEH, W. et al. 1994. Effects of EUK-8, a synthetic catalytic scavenger on hypoxia and acidosis induced damage in hippocampal slices. Neuropharmacology 33: 929-934.
80. 80. DOCTROW, S.R. et al. 1997. Salen-manganese complexes: combined superoxide dismutase/catalase mimics with broad pharmacological efficacy. Adv. Pharmacol. 38: 247-269.
81. 81. BRUCE, A. et al. 1996. Beta-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA 93: 2312-2316.
82. 82. TANGUY, S. et al. 1997. Free radicals in reperfusion-induced arrhythmias: a study with EUK8 a novel non protein catalytic antioxidant. Free Radical Biol. Med. 21: 945-954.
83. 83. PUCHEU, S., et al. 1993. Effect of iron overload in the isolated ischemic and reperfused rat heart. Cardiovasc. Drugs Ther. 7: 701-711.
84. 84. BARANDIER, C. et al. 1997. Vasodilatory effects of a salen-manganese complex with potent oxyradical scavenger activities. J. Vasc. Res. 34: 49-57.